Dr. Maria Teresa Abreu, MD

Dr. Abreu practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Abreu's NPI, 1598793374, was assigned on June 29, 2006. Dr. Abreu graduated from University of Miami, Miller School of Medicine in 1990. Dr. Abreu holds Florida license ME101004.

Dr. Abreu's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Abreu's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. Dr. Abreu is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Abreu to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abreu practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Abreu's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Abreu is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Abreu's licenses on file in 3 states: Florida, California and New York.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), colonoscopy, gastroenteritis, gastrointestinal bleeding, intestinal or bowel obstruction and irritable bowel syndrome (IBS) among the conditions Dr. Abreu treats.

CMS data shows 164 Medicare services from Dr. Abreu across 7 procedure codes in 2024, for 131 Medicare patients. Medicare paid $16,298 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 131 Medicare patients who saw Dr. Abreu in 2024. The largest group is 65 to 74, with 60 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 25% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abreu's median patient age at 53, with 52% women.

In 2024, Dr. Abreu wrote 276 Medicare Part D claims for 70 patients. 48% of them were for generic drugs. CMS names the drug for 153 of them, across 5 drugs with 11 or more claims each, at $1,892,519 in total drug cost. In 2023, CMS named 126 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Abreu for performance year 2024, reported as part of a group. Dr. Abreu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abreu as offering telehealth.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 273 papers to Dr. Abreu, published from 2001 to 2025. 2024 was the busiest year, with 22. The most frequent topics are Inflammatory Bowel Diseases, Crohn Disease and Colitis, Ulcerative. Dr. Abreu has published most often in Gastroenterology. Dr. Abreu's most frequent co-authors are Oriana Mazorra Damas, MD, Amar R. Deshpande, MD and David H. Kerman, MD.

Dmand AI links Dr. Abreu to 5 clinical trials, 2 of them phase 1 studies. 1 is still active or recruiting. Conditions studied include Crohn Disease, Inflammatory Bowel Diseases and Colitis, Ulcerative. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Abreu that name 1 trial.

CMS Open Payments shows 327 general payments to Dr. Abreu from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. UCB, Inc. paid the most, $134,185. It also lists 10 research payments totaling $10,045 from 2017 to 2022, naming 1 clinical trial.

Dmand AI lists 9 awards for Dr. Abreu, most recently The Sherman Prize in 2019.

Dr. Abreu graduated from University of Miami, Miller School of Medicine in 1990. Dr. Abreu is a member of AGA.

Dr. Abreu is in network with 7 carriers, including Elevance, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.